VALIRX PLC Logo

VALIRX PLC

Advancing oncology & women's health therapeutics and offering preclinical research services.

VAL | IL

Overview

Corporate Details

ISIN(s):
GB00BLH13C52
LEI:
213800VQKB9SJCQDET40
Country:
United Kingdom
Address:
STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

ValiRx PLC is a life science company dedicated to the early-stage development of therapeutics, with a primary focus on oncology and women's health. The company accelerates the translation of scientific discoveries into clinical applications by providing scientific, financial, and commercial expertise to progress its portfolio of drug candidates. Through its subsidiary, Inaphaea BioLabs, ValiRx also offers a suite of preclinical research services. The company's core strategy is to identify and advance innovative treatments for diseases with unmet medical needs, aiming to improve patient lives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 12:10
Holding(s) in Company
English 52.9 KB
2025-11-24 17:05
Holding(s) in Company
English 52.8 KB
2025-11-24 10:40
Holding(s) in Company
English 21.0 KB
2025-11-20 13:25
Result of GM & Issue of Equity
English 58.4 KB
2025-11-13 15:30
Holding(s) in Company
English 21.0 KB
2025-11-10 08:25
Holding(s) in Company
English 21.0 KB
2025-11-04 18:30
Posting of Circular and Notice of General Meeting
English 41.5 KB
2025-11-04 08:20
Result of WRAP Retail Offer
English 25.2 KB
2025-10-30 08:21
WRAP Retail Offer for up to £300,000
English 34.2 KB
2025-10-30 08:17
Fundraising of up to £1,050,000
English 84.0 KB
2025-10-14 08:00
Inaphaea Commercial update
English 21.7 KB
2025-09-29 08:00
Half-year Report
English 291.2 KB
2025-09-18 08:00
Inaphaea Commercial Update
English 23.6 KB
2025-08-26 08:00
Commercial update
English 17.7 KB
2025-08-07 11:51
ValiRx Awarded Grant from Open University
English 16.2 KB

Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VALIRX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VALIRX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG

Talk to a Data Expert

Have a question? We'll get back to you promptly.